Aevi Genomic Medicine Inc. (GNMX) Tumbled -15.96% or -0.22 To Price $1.19 On Tuesday


Aevi Genomic Medicine Inc. (GNMX) tumbled -15.96% or -0.22 to $1.19. It is nearly 363636 shares traded, which is 371.49% compare to the average total volume 97887. The market cap of GNMX is $70.31 million. The year to date change is -1581.99%. The 52 week price range is from $1.01 to $2.65. Price of GNMX have changed -7.24% during last week. It have changed -5.37% over last month, -30.88% over last 3 months, 22.61% over last 6 months and 24.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.61. It is 35.29% above current price. The 200-day Moving Averages for GNMX is 1.57. It is 31.93% above current price. The 52-week High is 2.65. It is 122.69% from the current price. The 52-week Low is 1.01. It is -15.13% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 5.54 on 2018-05-15. Short % to float is 0.65%. There are some statistics of GNMX. It is has market cap $70.31 million. The share outstanding is 59.34 million. The average volume is 97887. The percent of top 15 Institution holding is 22.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -125.70%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -103.58%.


Tags:

Share this post